Which Companies currently reap the swine flu windfall?
CHICAGO (Reuters) – Healthcare companies are reaping the benefits of a global swine flu pandemic, brightening what might otherwise have been a dismal third quarter and bringing new focus on the market for vaccines. Large European pharmaceutical companies are reporting windfall sales from flu drugs and H1N1 vaccines. Small biotechs are winning fresh attention from investors and governments looking for quick, less expensive ways of making flu vaccines to protect their populations. And diagnostic companies have been growing revenues as doctors order more flu tests. “Pretty much everyone who does something in influenza in has gained from it,” said Hedwig Kresse, an infectious diseases analyst at Datamonitor in London. “From a sales perspective, the big players certainly will see a very significant windfall of this pandemic this year,” Kresse said in a telephone interview. Swiss drugmaker Novartis AG said this week it expects the H1N1 flu vaccine to contribute about $400 million to $700 mil
Companies reap the swine flu windfall Fri Oct 23, 2009 12:43pm EDT By Julie Steenhuysen – Analysis CHICAGO (Reuters) – Healthcare companies are reaping the benefits of a global swine flu pandemic, brightening what might otherwise have been a dismal third quarter and bringing new focus on the market for vaccines. Large European pharmaceutical companies are reporting windfall sales from flu drugs and H1N1 vaccines. Small biotechs are winning fresh attention from investors and governments looking for quick, less expensive ways of making flu vaccines to protect their populations. And diagnostic companies have been growing revenues as doctors order more flu tests. “Pretty much everyone who does something in influenza in has gained from it,” said Hedwig Kresse, an infectious diseases analyst at Datamonitor in London. “From a sales perspective, the big players certainly will see a very significant windfall of this pandemic this year,” Kresse said in a telephone interview. Swiss drugmaker Nova
CHICAGO (Reuters) – Healthcare companies are reaping the benefits of a global swine flu pandemic, brightening what might otherwise have been a dismal third quarter and bringing new focus on the market for vaccines. Sources: http://www.reuters.
